Fairvalue-Calculator Fairvalue-Calculator
EN DE

Daesung Microbiological Labs. Co (036480) Fair Value & Analysis

Healthcare · KR · Market cap 24.5B KRW

Price5,950 KRW
Fair Value1,970 KRW
Upside-66.9%
Quality95/100
Evidence: High Range 1,189 KRW – 2,755 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Daesung Microbiological Labs. Co (036480) currently trades at 5,950 KRW, while our model-based Fair Value estimate is 1,970 KRW — implying the stock looks roughly 66.9% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Daesung Microbiological Labs. Co., Ltd. manufactures and sells vaccines for swine, poultry, canine, cattle, and fish in South Korea. It offers antibiotics and antibacterials, parasiticides and disinfectants, probiotics and enzyme products, and nutrients and pharmaceuticals. The company also exports its products. Daesung Microbiological Labs. Co., Ltd. was founded in 1966 and is headquartered in Uiwang-si, South Korea.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -88% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -62%

Frequently asked questions

Is Daesung Microbiological Labs. Co (036480) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,970 KRW versus a price of 5,950 KRW — about −67% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 036480?
Our 21-model fair value for Daesung Microbiological Labs. Co is 1,970 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 5,950 KRW.
What is the quality score of 036480?
Daesung Microbiological Labs. Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.